Wild-Type Myoblasts Rescue the Ability of Myogenin-Null Myoblasts to Fusein Vivo  by Myer, Anita et al.
DEVELOPMENTAL BIOLOGY 185, 127±138 (1997)
ARTICLE NO. DB978565
Wild-Type Myoblasts Rescue the Ability
of Myogenin-Null Myoblasts to Fuse in Vivo
Anita Myer,* Daniel S. Wagner,* Jay L. Vivian,* Eric N. Olson,²
and William H. Klein*,1
*Department of Biochemistry and Molecular Biology, The University of Texas M. D. Anderson
Cancer Center, Houston, Texas 77030; and ²Department of Molecular Biology and Oncology,
Hamon Center for Basic Research in Cancer, University of Texas Southwestern
Medical Center, Dallas, Texas 75235
Skeletal muscle is formed via a complex series of events during embryogenesis. These events include commitment of
mesodermal precursor cells, cell migration, cell±cell recognition, fusion of myoblasts, activation of structural genes, and
maturation. In mice lacking the bHLH transcription factor myogenin, myoblasts are speci®ed and positioned correctly,
but few fuse to form multinucleated ®bers. This indicates that myogenin is critical for the fusion process and subsequent
differentiation events of myogenesis. To further de®ne the nature of the myogenic defects in myogenin-null mice, we
investigated whether myogenin-null myoblasts are capable of fusing with wild-type myoblasts in vivo using chimeric mice
containing mixtures of myogenin-null and wild-type cells. Chimeric embryos demonstrated that myogenin-null myoblasts
readily fused in the presence of wild-type myoblasts. However, chimeric myo®bers did not express wild-type levels of
muscle-speci®c gene products, and myo®bers with a high percentage of mutant nuclei appeared abnormal, suggesting that
the wild-type nuclei could not fully rescue mutant nuclei in the myo®bers. These data demonstrate that myoblast fusion
can be uncoupled from complete myogenic differentiation and that myogenin regulates a speci®c subset of genes with
diverse function. Thus, myogenin appears to control not only transcription of muscle structural genes but also the extracellu-
lar environment in which myoblast fusion takes place. We propose that myogenin regulates the expression of one or more
extracellular or cell surface proteins required to initiate the muscle differentiation program. q 1997 Academic Press
INTRODUCTION form a committed myoblast, whereas myogenin is essential
for myoblast differentiation. The function of MRF4 is less
clear, but one role might be in the maintenance and repairFormation of vertebrate skeletal muscle begins within
of adult muscle (Zhang et al., 1995; Patapoutian et al., 1995;the dorsomedial region of each developing somite where
Olson et al., 1996). While the knockout studies have pro-speci®c cells become committed to the myogenic fate
vided information on the general roles of the myogenic fac-(Buckingham, 1992; Christ and Ordahl, 1995). This commit-
tors, precisely how these factors function in myoblast speci-ment is a result of external signals from surrounding tissues.
®cation and differentiation is unknown. For example, inThe committed myoblasts migrate to speci®c areas in the
myogenin-null mice, most myoblasts are speci®ed and cor-embryo where they undergo cell fusion with one another
rectly positioned, but the myoblasts can neither fuse norto form postmitotic multinucleated ®bers. At this time,
differentiate into myocytes (Hasty et al., 1993; Nabeshimamuscle-speci®c genes are activated, and the myo®bers sub-
et al., 1993; Rawls et al., 1995; Venuti et al., 1995). Presum-sequently mature to adult skeletal muscle ®bers.
ably, myogenin must control the activity of genes whoseRecent studies on mice with null mutations in the genes
products are required for these events.encoding the four bHLH myogenic regulators MyoD, Myf5,
Several lines of evidence point to extracellular factorsmyogenin, and MRF4 have demonstrated the importance of
being essential for myogenesis, in¯uencing the initial speci-these transcription factors during muscle development in
®cation and patterning events as well as terminal differenti-vivo (Olson and Klein, 1994; Lassar and Munsterberg, 1994;
ation (Florini et al., 1994; Munsterberg and Lassar, 1995;Yun and Wold, 1996). Either MyoD or Myf5 is required to
Stern and Hauschka, 1995; Cossu et al., 1996; Pownall et
al., 1996). A reasonable hypothesis is that myogenin con-
trols the production of at least one extracellular or cell sur-1 To whom correspondence should be addressed.
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dase activity in tail clippings from several E18.5 embryos in whichface protein required for myoblast fusion. Myogenin could
all cells contained the ROSA 26 gene. These latter embryos werecontrol production of a factor that promotes cell fusion or
obtained by breeding male mice heterozygous for the myogenin-alternatively a factor that overcomes an inhibitory process.
null allele and carrying two copies of ROSA 26 with heterozygousEither model would explain the inability of most myogenin-
myogenin-null females carrying either one or two copies of ROSAnull myoblasts to undergo fusion in myogenin knockout
26. Southern analysis of StuI-digested DNA with a probe (pR265*,mice. A simple way to test this hypothesis is to generate
a gift from Brian Zambrowicz, Lexicon) that distinguished the
genetic chimeras with mixtures of myogenin-null and wild- ROSA 26 insertion from the wild-type allele was used to divide
type cells and determine if mutant myoblasts can fuse in the embryos into two sets: those that contained one copy and those
the presence of wild-type cells. We report here that myo- that contained two copies of the ROSA 26 transgene. Southern
genin-null myoblasts readily fuse in the presence of wild- analysis with the pR265* probe also showed that ES cell line #4
type myoblasts to form muscle ®bers in chimeric embryos. was hemizygous and ES cell line 2C1 was homozygous for ROSA
Wild-type myoblasts thus provide the correct extracellular 26. Thus, b-galactosidase activity from embryos that contained one
copy of ROSA 26 was used to determine the percentage chimerismenvironment for fusion with mutant myoblasts to occur.
in the chimeric embryos generated from #4 ES cells, while embryosOur experiments demonstrate that myogenin-null myo-
that contained two copies of ROSA 26 were used to calculate theblasts are incapable of producing the appropriate environ-
percentage chimerism in the chimeric embryos derived from ESment in vivo, a result not predicted from culturing mutant
cell line 2C1.myoblasts in vitro. Yet, despite this ability to fuse in the
Histology. For b-galactosidase staining, embryos were skinnedpresence of wild-type myoblasts, nuclei from myogenin-
and stained as whole mounts. Tongues, limbs, diaphragms, and ribmutant myoblasts appeared incapable of completing the
cages, minus internal viscera, were ®xed in 2% paraformaldehyde,myogenic program.
0.2% glutaraldehyde in PBS. After ®xation, the tissue was rinsed
in PBS and stained overnight in 5 mM potassium ferricyanide, 4
mM potassium ferrocyanide, 0.7 mM MgCl2 , and 1 mg/ml X-gal
MATERIALS AND METHODS (stock 25 mg/ml in dimethylformamide) in PBS. The tissue was
post®xed in formalin, dehydrated in an isopropanol series, embed-
ded in paraplast, sectioned into 6-mm-thick slices, and counter-Generation of myogenin-null embryonic stem (ES) cells and ge-
stained with hematoxylin and eosin for analysis.netic chimeras. Blastocysts were obtained from breeding mice
For immunohistology, skinned and unskinned forelimbs wereheterozygous for myogenin and carrying one to two copies of the
incubated overnight at 47C in 50% sucrose in 0.1 M sodium phos-lacZ transgene ROSA 26 (Friedrich and Soriano, 1991). ES cells
phate buffer, pH 7.4, embedded in tissue freezing medium (Electronwere derived from blastocysts as described by Robertson (1987)
Microscopy Sciences, Ft. Washington, PA), and frozen in isopentaneexcept that the disaggregation of the inner cell mass was done by
cooled on dry ice. Sections were cut into 10-mm-thick slices in asuccessive incubations (every other day) with trypsin (GIBCO/BRL)
for approximately 5 min prior to adding media. The ES cells were cryostat and placed on silane-coated microscope slides (Histology
genotyped by Southern analysis of EcoRI-digested genomic DNA Control Systems, Glen Head, NY). The slides were thawed and
using the myogenin cDNA as a probe (Hasty et al., 1993) and bgeo stained with a myosin heavy chain (MHC-fast) antibody (MY-32,
as a probe for ROSA 26 (Friedrich and Soriano, 1991). Seven ROSA Sigma) at 1:400 dilution using Zemed's Histomouse SP kit.
26-positive ES cells, of which 4 were homozygous and 3 were het- For hematoxylin staining, embryos were skinned and processed
erozygous for the myogenin-null allele, were injected into wild- in a similar fashion as described above, but without dissection prior
type blastocysts as described by Bradley (1987), except that about to staining. Paraf®n sections were dewaxed, rehydrated, and stained
20 ES cells rather than 8±10 were injected per blastocyst. Two with Heidenhain's iron hematoxylin (Stevens and Wilson, 1996).
ES cell lines, #4 and 2C1, heterozygous and homozygous for the Measuring diaphragm widths. Sagittal sections of diaphragms,
myogenin-null allele, respectively, were used for the generation of prepared as described for b-galactosidase staining, were examined
chimeric embryos and adults. Embryos were analyzed at Embryonic at 2001magni®cation using a reticule marked with 100 gradations
Day 18.5 (E18.5). for measuring the width of the diaphragms. Ten ®elds were mea-
Quanti®cation of the extent of overall chimerism. b-Galactosi- sured for each embryo and the average value and standard error of
dase activity was determined by modi®cation of a method devel-
the mean determined.
oped by Simon and Lis (1987). ES cells and tail clippings from
RT-PCR analysis. Hindlimbs were dissected from E18.5 chime-E18.5 embryos and 8-day-old pups were homogenized in a ground
ric embryos, and total cellular RNA was isolated by guanidine dena-glass homogenizer in 1 ml of assay buffer (1 mM MgCl2; 50 mM
turation and phenol extraction (Chomzynski and Sacchi, 1987).potassium phosphate, pH 7.0±7.5). An 8 mM solution of chloro-
Reverse transcription of 1 mg of total RNA and subsequent PCRphenol red-b-galactopyranoside (Boehringer-Mannheim) in assay
ampli®cation using primers speci®c to muscle-speci®c creatine ki-buffer was dispensed in 1-ml aliquots into disposable cuvettes. A
nase (MCK) and L7 sequences were performed as described in Rawlshomogenate of 10±20 ml was added to each cuvette, the samples
et al. (1995). PCR primers were designed that ¯anked the neo inser-were incubated at either 37 or 427C, and the reaction product was
tion of the myogenin-null allele and were used to selectively am-monitored spectrophotometrically (570 nm) at 30-min intervals
plify the wild-type myogenin transcript. The following primersfor 90 min. To normalize for protein content, Bio-Rad's Total
were used: upper primer, CATCCCCCTATTTCTACCAG (baseProtein Macro-Assay was employed using bovine serum albumin
pairs 65±850); lower primer, GAGTTGGGGTTGGTCGCCGAas a standard. b-Galactosidase activity was calculated as A570/
(base pairs 376±396). PCR ampli®cation was done for 26 cycles,min/mg protein.
resulting in a 331-bp product. All products were quanti®ed on aThe percentage of ES cells contributing to a chimeric E18.5 em-
phosphorimager and relative abundance was calculated using L7 asbryo (percentage chimerism) was calculated as the b-galactosidase
activity of the chimeric embryo divided by the averagedb-galactosi- an internal control (Hollenberg et al., 1993).
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ited spinal curvature and edema similar to myogenin-null
embryos (Hasty et al., 1993). Histological examination con-
®rmed that overtly abnormal embryos invariably had skele-
tal muscle defects (see below). The mutant phenotype was
more severe as the percentage of mutant cells increased,
implying that wild-type myoblasts could not overcome the
de®ciency when large numbers of myogenin-null cells were
present. Nevertheless, in all the chimeric embryos exam-
ined, mutant myoblasts readily fused in the presence of
wild-type myoblasts to form myo®bers.
Myogenin-Mutant Myoblasts Readily Fuse with
Each Other and with Wild-Type Myoblasts
Histological examination of limb (Fig. 2) and intercostal
muscle (Fig. 3) showed extensive contribution of mutant
FIG. 1. Phenotypes of chimeric embryos with varying percentages
myoblasts to myo®bers from chimeric embryos. Chimerasof myogenin-mutant cells. b-Galactosidase activity was measured
exhibiting either wild-type (Fig. 2D) or overt mutant (Figs.in extracts of tail clippings from E18.5 chimeric embryos and then
2E and 2F) phenotypes contained large numbers of mutantused to quantify the percentage chimerism. Chimeras with overt
nuclei within their myo®bers, and the density of myo®bersmyogenin-mutant phenotypes are indicated by gray bars and those
was much greater in chimeric embryos than in pure myo-with wild-type phenotypes by black bars. WT indicates wild-type
embryos and mut indicates mutant embryos. genin-null controls (compare Fig. 2B with Figs. 2D±2F). In
some cases, intense b-galactosidase staining could be seen
restricted to areas around the nuclear periphery. In these
cases, it appeared that mutant nuclei (arrowheads in Figs.
2D, 3A, and 3B) were interspersed with wild-type nucleiRESULTS
(arrows in Figs. 2D, 3A, and 3B), suggesting that hybrid myo-
®bers had formed between wild-type and mutant myoblasts.Generation of Myogenin-Null Chimeric Mice
In other examples, long stretches of staining were observed
throughout the myo®ber (brackets in Fig. 2F). These resultsTo create genetic chimeras with marked myogenin-null
cells, ES cells were generated from blastocysts derived from suggested that myogenin-mutant myoblasts need not contact
a wild-type myoblast for fusion to occur. This was not unex-crosses between heterozygous myogenin-mutant mice car-
rying one or two copies of a ubiquitously expressed lacZ pected since at least some myoblasts fuse to form myo®bers
in homozygous myogenin-null embryos. It was possible thattransgene, ROSA 26 (Friedrich and Soriano, 1991). Homozy-
gous and heterozygous myogenin-mutant ES cells were in- in some intensely stained ®bers diffusion of the b-galactosi-
dase resulted in large areas of staining. Myo®bers from bothjected into unmarked wild-type blastocysts, and chimeric
embryos were collected at E18.5 when most skeletal muscle high- (66%) and low-percentage (35%) chimeras expressed
MHC as shown by immunostaining with a MHC antibodydifferentiation had taken place (Venuti et al., 1995). The
contribution of myogenin-null cells in these chimeric em- (Figs. 4A±4D), and these myo®bers displayed ordered stria-
tions, re¯ecting the ability of muscle structural proteins tobryos ranged from 1 to 73% as determined by a quantitative
b-galactosidase analysis of tail extracts (Fig. 1; see Materials assemble correctly (Figs. 3A, 3B, and 4E).
Myogenin-null embryos are severely de®cient in produc-and Methods for a description of this measurement). This
value did not necessarily re¯ect the amount of chimerism ing myo®bers, but a few residual ®bers can always be found,
particularly in the trunk and limb (e.g., Figs. 2B and 4B). Theseen in all tissues since b-galactosidase activity varied
among the different tissues within a given animal. More- origin of the residual ®bers is uncertain, but we routinely
observed very few or no ®bers in the tongue and diaphragm.over, within a given region of muscle, the extent of chime-
rism varied as observed by X-Gal staining. Importantly, we Hence, analysis of tongue and diaphragm muscle provided
a way of assessing the ability of mutant myoblasts to fuseobserved homozygous mutant cells populating all skeletal
muscles of the body in a manner similar to that observed in the absence of a background of residual ®bers. Tongue
muscle from chimeric embryos displaying wild-type (Fig.in skeletal muscle of chimeric embryos derived from hetero-
zygous ES cells. These results demonstrated that wild-type 5D) or myogenin-mutant phenotypes (Figs. 5E and 5F)
showed abundant myo®ber formation, whereas pure myo-myoblasts did not overproliferate at the expense of myo-
genin-mutant myoblasts. genin-null embryos had virtually no ®bers (Fig. 5B). b-Ga-
lactosidase staining could be seen in nuclei of longitudinalThe chimeric embryos generated from homozygous myo-
genin-mutant ES cells fell into two overlapping classes (Fig. (Fig. 4E, arrows) and cross-sectioned ®bers (Fig. 5E, arrow-
head). However, in contrast to wild-type tongues (Fig. 5A)1). Embryos appeared normal when approximately 40% or
less of their cells lacked myogenin. However, when em- or tongues dissected from control embryos generated from
heterozygous ES cells (Fig. 5C), the muscle from chimericbryos had more than about 40% mutant cells, they exhib-
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FIG. 2. Hindlimb muscle from chimeric embryos stained for b-galactosidase activity. E18.5 hindlimbs were whole-mount stained for b-
galactosidase, paraf®n embedded, sectioned, and counterstained with hematoxylin and eosin. Blue staining indicates cells or nuclei that
express the ROSA 26 lacZ transgene, while purple staining indicates the nuclei. (A) An embryo heterozygous for myogenin and carrying
the ROSA 26 allele. (B) A myogenin-null embryo carrying the ROSA 26 allele. (C) A chimera derived from the #4 ES cell line heterozygous
for myogenin. (D±F) Chimeras derived from the 2C1 myogenin-null ES cell line. The chimera in (D) had a wild-type phenotype, while
those in (E) and (F) had overt mutant phenotypes prior to dissection. In (D), arrowheads indicate mutant and arrows wild-type nuclei. In
(F), a region consisting solely of mutant nuclei is bracketed. Magni®cation of all micrographs in this and subsequent ®gures unless
indicated is 2001. Bar in (B)  70 mm.
tongues lacked the typical repeated pattern of longitudinal ®ciently fuse within this tissue as shown by intense b-
galactosidase staining of myo®bers (Figs. 6D±6F). Exten-and cross-sectional ®bers, and muscle ®bers were generally
less organized, particularly in chimeric embryos with a high sive ®ber formation was observed even in regions where
wild-type myoblasts were rare. For example, Fig. 6Epercentage of myogenin-null cells (Figs. 5E and 5F).
Diaphragm muscle from another series of embryos shows long stretches of ®bers staining heavily for b-galac-
tosidase. As was observed with tongue muscle, diaphragmdemonstrated that myogenin-mutant myoblasts could ef-
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FIG. 3. Hybrid nuclei in intercostal muscle from chimeric embryos. An E18.5 myogenin-null chimeric embryo with an overt wild-type phenotype
was whole-mount stained for b-galactosidase activity and treated in a manner similar to the embryos described in the legend to Fig. 2. (A) and
(B) show different sections of intercostal muscle. Blue indicates b-galactosidase activity and is seen in a striated pattern in the cytoplasm as well
as in surrounding mutant nuclei (arrowheads). Wild-type nuclei stain purple (arrows). Magni®cation is 1501 and the bar indicates 50 mm.
muscle from the low-percentage chimeric embryos ap- myo®bers from diaphragms of higher percentage chimeras
appeared less organized and grossly abnormal (Figs. 6Apeared morphologically similar to that from the wild-type
control embryos (Figs. 6A and 6C versus Fig. 6D), while and 6C versus Figs. 6E and 6F).
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FIG. 4. MHC expression and striated patterns in chimeric limb muscle. E18.5 forelimbs were cryosectioned and immunostained for
MHC (A±D) or paraf®n-sectioned for Heidenhain's iron hematoxylin staining (E) (magni®cation is 1501). MHC staining is red±brown,
while nuclei are purple. (A) An embryo heterozygous for the myogenin-mutant allele (B) A myogenin-null embryo. (C±E) Chimeras derived
from the myogenin-null ES cell line in which (C) and (E) had wild-type phenotypes and (D) had a mutant phenotype. Bar in (B)  70 mm,
magni®cation is 1501, and bar in (E)  30 mm.
Because diaphragms from myogenin-null embryos had width as a rough measure of the amount of muscle forma-
tion that occurred in four chimeric embryos with varyingvirtually no muscle, they were four to ®ve times narrower
than wild-type embryos (Fig. 6). Thus, we used diaphragm percentages of mutant cells. In three cases, the width of the
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FIG. 5. Tongue muscle from chimeric E18.5 embryos stained for b-galactosidase activity. (A) An embryo heterozygous for myogenin and
carrying the ROSA 26 allele. (B) A myogenin-null embryo carrying the ROSA 26 allele. (C) A chimera derived from the ES cell line
heterozygous for myogenin. (D±F) Chimeras derived from the myogenin-null ES cell line. (D) had a wild-type phenotype and (E) and (F)
had mutant phenotypes. Arrows point to mutant nuclei in longitudinal ®bers, while the arrowhead points to a mutant nucleus in a ®ber
cross-section. Bar  70 mm.
diaphragm was statistically the same or very close to the genin-null myoblasts are capable of participating in the
events of myoblast fusion.width of the wild-type controls (e.g., compare Figs. 6A and
6C with 6D and 6F). This was true for diaphragms from
both low- and high-percentage chimeric embryos. In one
Muscle-Speci®c Gene Expression in Chimericcase, the diaphragm width was less than that of the wild
Embryostype, but even then the width was signi®cantly greater than
that of a diaphragm from a pure myogenin mutant (compare Myo®bers from chimeric embryos with high percentages
of myogenin-null myoblasts were disorganized and in manyFig. 6B with 6E). These data support the view that myo-
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FIG. 6. Diaphragm muscle from chimeric embryos stained for b-galactosidase activity. (A) An embryo homozygous for myogenin and
carrying the ROSA 26 allele. (B) A myogenin-null embryo carrying the ROSA 26 allele. (C) A chimera derived from the ES cell line
heterozygous for myogenin. (D±F) Chimeras derived from the myogenin-null ES cell line. (D) had a wild-type phenotype and (E) and (F)
had mutant phenotypes. Bar  70 mm.
cases morphologically abnormal. To further explore the were incapable of expressing myogenin, these results indi-
cate that expression of the myogenin gene from wild-typecharacter of the myo®bers in the chimeric embryos, we
monitored the expression of the MCK gene using RT-PCR. nuclei was insuf®cient to achieve normal levels of MCK
transcripts. In high-percentage chimeric embryos, newlyAs reported previously, MCK is not expressed at signi®cant
levels in myogenin-null embryos (Hasty et al., 1993; Rawls synthesized myogenin might have been translocated into
both wild-type and mutant nuclei, but diluted to such anet al., 1995). RNA extracted from limb muscle of chimeric
embryos had reduced levels of MCK with respect to wild- extent that each nucleus expressed less MCK. Alternatively,
myogenin might have been unable to translocate into mu-type controls (Fig. 7). The levels of MCK transcripts also
decreased proportionally with decreasing levels of myo- tant nuclei or if translocation did occur, myogenin was un-
able to function.genin transcripts (Fig. 7). Because myogenin-mutant nuclei
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cell cycle, become aligned, and then fuse to form synsytia.
Since skeletal myoblasts cannot fuse with other cell types,
the fusion process must also involve highly speci®c cell±
cell recognition events and interactions. In addition, myo-
blasts are exquisitely sensitive to their environment and
only enter into the differentiation pathway in the presence
of the appropriate extracellular concentrations of growth
factors and matrix molecules. Thus, perturbations in any of
a number of intrinsic or extrinsic factors could, in principle,
prevent myoblast fusion. A variety of membrane proteins
are known to be involved in myotube formation, including
N- and V-CAM, N- and M-cadherins, and integrins, and
recently a myoblast-expressed factor, meltrin-a, which be-
longs to the metalloproteinase/disintegrin protein family
was shown to be required for myotube formation (Yagami-
Hiromasa et al., 1995).
Previous studies have demonstrated that myogenin is re-
quired for normal myoblast fusion and differentiation in
vivo. However, if myogenin-null myoblasts are placed in
tissue culture, they are apparently able to fuse and differen-
tiate with the same ef®ciency as wild-type myoblasts
(Nabeshima et al., 1993; Rawls et al., 1995). An important
question that arises from these observations is whether the
FIG. 7. MCK and myogenin expression in chimeric embryos. acquired propensity for fusion in vitro is due to an intrinsic
RNA was extracted from hindlimb muscle of wild-type, myogenin-
change within each myoblast or to a difference in the exter-null, and chimeric embryos and subjected to RT-PCR using primers
nal environment perceived by each cell. We have attemptedspeci®c for MCK and myogenin. Results from each embryo are
to address these questions by testing whether myogenin-presented as percentage wild-type. PCR conditions were within the
mutant myoblasts can sense the presence of wild-type myo-linear range of input RNA as established with control RNA from
wild-type muscle. blasts in vivo and whether in their presence their ability to
form myotubes can be restored. Our results lead to several
important insights into the molecular defects associated
with the myogenin-mutant phenotype and the role of extra-
Low-Percentage Chimeras Are Viable and Fertile cellular signals in myoblast fusion. First, myogenin-mutant
myoblasts have the potential to fuse in vivo, but fail to do
We allowed a few females carrying chimeric embryos to so because of a nonpermissive environment. Second, myo-
come to term. In one litter, two chimeric mice were viable genin-mutant myoblasts appear to be capable of recognizing
after birth, one with 28% myogenin-null cells and one with and fusing with wild-type myoblasts under the appropriate
18% (Fig. 8A). The 18% chimera survived to adulthood and conditions. Third, myogenin is required in vivo to establish
was fertile. The 28% chimera appeared normal as a neonate
an extracellular environment compatible with fusion.
but did not grow as well as its littermates and was killed
While the vast majority of myoblasts cannot fuse in myo-
at 8 days. Muscle-containing regions from this mouse were
genin-null mice, there are always some residual myo®bers
®xed, stained for b-galactosidase, and sectioned. As for chi-
observed with seemingly normal morphology, particularly
meric embryos, extensive contribution of mutant myo-
in limb and intercostal muscle. Furthermore, in myogenin-
blasts to adult myo®bers was seen (Fig. 8B). In the example
mutant mice, the absence of myogenin has a less dramatic
shown in Fig. 8B, forelimb muscle appeared normal, and
effect on myo®ber formation before E13.5 (when primary
myo®bers containing mutant nuclei had easily observable myo®ber formation is occurring) than after (when secondary
banding patterns. However, the fact that the animal's myo®ber formation occurs) (Venuti et al., 1995). In chimeric
growth was retarded suggested that myogenin levels were mice, wild-type myoblasts could provide an external envi-
insuf®cient to restore long-term viability. These results ronment that is largely lacking in the myogenin-null em-
con®rmed our experiments with chimeric embryos and in- bryos by several means. The wild-type cells could secrete a
dicated that wild-type myoblasts were capable of enhancing fusion-promoting factor whose synthesis depends on myo-
mutant myoblast fusion in postnatal life.
genin. Alternatively, a myogenin-dependent product could
be present on the surface of the wild-type cells, and mutant
cells could fuse upon contact. In contrast, the mutant myo-
DISCUSSION blasts could be changed to a fusion-competent state by di-
rect or indirect means by wild-type myoblasts and then
confer competence to other mutant myoblasts. Finally,The formation of a multinucleated myotube requires a
multistep process in which proliferating myoblasts exit the wild-type myoblasts could downregulate some factor that
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FIG. 8. Viability and chimeric myo®bers in P8 pups. (A) P8 siblings. The arrow points to a pup with approximately 28% of its cells
lacking myogenin; the pup on the right had 18% lacking myogenin. The pup in the middle did not have detectable numbers of myogenin-
mutant cells. Chimerism can also be detected by the agouti coat coloring. (B) Forelimb muscle of the 28% chimeric pup stained for b-
galactosidase activity. Bar  70 mm.
inhibits fusion, thus allowing mutant myoblasts that are be most easily explained by postulating that myogenin is re-
sponsible for the production of at least one factor involved inprimed to fuse to undergo the fusion process.
The in vivo properties of myogenin-null myoblasts could myoblast fusion, although as mentioned above this need not
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be the case. In myogenin-null mice, this factor could be pro- Wild-type myoblasts clearly enhance the fusion ef®ciency
of myogenin-null myoblasts, but their presence does notduced at low levels in myoblasts or nearby ®broblasts in a
myogenin-independent manner. The residual myo®bers ob- restore normal muscle formation in chimeric embryos or
postnatal mice. The myogenin mutation affects myoblastserved in the mutant mice might form stochastically when a
small group of cells within a muscle-forming region produced fusion as well as activation of muscle-speci®c genes and
cannot be classi®ed as strictly cell autonomous or non-cellenough of the putative factor to promote myogenesis. More-
over, this same factor might be present in the serum required autonomous. The chimeric analysis strongly suggests that
myogenin controls the expression of at least one gene whosein vitro for cell viability and thus promote myogenesis in
cultured myoblasts. This would explain why homozygous product is required for myoblast fusion and that this product
affects the external environment. Because myogenin-nullmutant myoblasts readily differentiate into myotubes with
the same ef®ciency as wild-type myoblasts when they are myoblasts can respond to the environment provided by the
wild-type cells, the surfaces of the mutant cells must beremoved from embryos or neonates and placed in culture
(Nabeshima et al., 1993; Rawls et al., 1995). competent for fusion. A simple model is that myogenin is
essential for the production of a fusion-promoting ligandSeveral secreted factors that are actively synthesized in
myoblasts have been reported to promote muscle differenti- but not for its receptor.
ation. In particular, IGF-I and IGF-II have been shown to
drive the differentiation of myoblasts in culture (Florini et
al., 1994; McFarland et al., 1994; Engert et al., 1996), and ACKNOWLEDGMENTS
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